Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure

Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty

(2015) Marianne O. Price et al.   CORNEA

Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation

(2015) Grace E. Boynton et al.   CORNEA

A Randomized Controlled Trial Comparing Dexamethasone with Loteprednol Etabonate on Postoperative Photorefractive Keratectomy

(2015) Onsiri Thanathanee et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Corneal Confocal Microscopy in Dry Eye Treated with Corticosteroids

(2015) Edoardo Villani et al.   OPTOMETRY AND VISION SCIENCE

Effects of Topical Loteprednol Etabonate on Tear Cytokines and Clinical Outcomes in Moderate and Severe Meibomian Gland Dysfunction: Randomized Clinical Trial

(2014) Hun Lee et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Effect of Loteprednol Etabonate 0.5% on Initiation of Dry Eye Treatment With Topical Cyclosporine 0.05%

(2014) John D. Sheppard et al.   Eye & Contact Lens-Science and Clinical Practice

The Core Mechanism of Dry Eye Disease Is Inflammation

(2014) Yi Wei et al.   Eye & Contact Lens-Science and Clinical Practice

Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle

(2013) Rebecca Gupte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients

(2012) Lan Gong et al.   CLINICAL THERAPEUTICS

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis

(2012) Minjie Chen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety

(2012) Veysi Öner et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery

(2012) Rajesh K. Rajpal et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery

(2012) Stephen S. Lane et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects

(2012) Timothy L. Comstock et al.   PEDIATRIC DRUGS

Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use

(2012) Michael Amon et al.   INTERNATIONAL OPHTHALMOLOGY

Risk factors for steroid response among cataract patients

(2011) David F. Chang et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Steroid-Induced Iatrogenic Glaucoma

(2011) M. Reza Razeghinejad et al.   OPHTHALMIC RESEARCH

Steroid-induced ocular hypertension with loteprednol etabonate 0.2%—A case report

(2011) Edeline Lu et al.   OPTOMETRY

Iatrogenic Glaucoma Secondary to Medications

(2010) M. Reza Razeghinejad et al.   AMERICAN JOURNAL OF MEDICINE

Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis

(2010) Brett P Bielory et al.   Current Opinion in Allergy and Clinical Immunology

Topical Loteprednol Pretreatment Reduces Cyclosporine Stinging in Chronic Dry Eye Disease

(2010) John D. Sheppard et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Effects of Loteprednol/Tobramycin Versus Dexamethasone/Tobramycin on Intraocular Pressure in Healthy Volunteers

(2009) Edward J Holland et al.   CORNEA

Attenuation of Ocular Hypertension With the Use of Topical Loteprednol Etabonate 0.5% in Steroid Responders After Corneal Transplantation

(2009) Edward J Holland et al.   CORNEA

Steroid-induced Intraocular Pressure Elevation or Glaucoma After Penetrating Keratoplasty in Patients With Keratoconus or Fuchs Dystrophy

(2009) Mesut Erdurmus et al.   CORNEA

Visual Loss Caused by Corticosteroid-Induced Glaucoma: How to Avoid It

(2009) George L. Spaeth et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Treatment of ocular inflammatory conditions with loteprednol etabonate

(2008) C E Pavesio et al.   BRITISH JOURNAL OF OPHTHALMOLOGY